Journal Publications

Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.

Article Title Journal
Directional Inconsistency Between Response Evaluation Criteria in Solid Tumors (RECIST) Time to Progression and Response Speed and Depth European Journal of Cancer
Estimation of Tumour Regression and Growth Rates During Treatment in Patients with Advanced Prostate Cancer: A Retrospective Analysis The Lancet Oncology
Myocarditis Associated with Immune Checkpoint Inhibitors: an Expert Consensus on Data Gaps and a Call to Action The Oncologist
Predicting Survival of Pancreatic Cancer Patients Treated with Gemcitabine Using Longitudinal Tumour Size Data Cancer Chemotherapy and Pharmacology
ePCR: An R-package for Survival Time and Time-to-Event Prediction in Advanced Prostate Cancer, Applied to Real-World Patient Cohorts Bioinformatics
Effect of Breast Irradiation on Cardiac Disease in Women Enrolled in BCIRG-001 at 10-Year Follow-Up Radiation Oncology
A Patient-Level Data Meta-Analysis of Standard-of-Care Treatments from Eight Prostate Cancer Clinical Trials Nature Scientific Data
On the relationship between tumour growth rate and survival in non-small cell lung cancer PeerJ
“Threshold‐crossing”: A Useful Way to Establish the Counterfactual in Clinical Trials? Clinical Pharmacology & Therapeutics
A DREAM Challenge to Build Prediction Models for Short-Term Discontinuation of Docetaxel in Metastatic Castration-Resistant Prostate Cancer Journal of Clinical Oncology
Obstruction Predicts Worse Long-term Outcomes in Stage III Colon Cancer: A Secondary Analysis of the N0147 Trial Surgery
Individual Patient Data Analysis of Randomized Clinical Trials: Impact of Black Race on Castration-resistant Prostate Cancer Outcomes European Urology
Assessment of a Prognostic Model, PSA Metrics and Toxicities in Metastatic Castrate Resistant Prostate Cancer using Data from Project Data Sphere. PLOS ONE
Comparative Effectiveness of Mitoxantrone plus Prednisone versus Prednisone alone in Metastatic Castrate-resistant Prostate Cancer after Docetaxel Failure The Oncologist

Pages